High quality genome annotation and expression visualisation of a mupirocin-producing bacterium
- PMID: 35511780
- PMCID: PMC9070926
- DOI: 10.1371/journal.pone.0268072
High quality genome annotation and expression visualisation of a mupirocin-producing bacterium
Abstract
Pseudomonas strain NCIMB10586, in the P. fluorescens subgroup, produces the polyketide antibiotic mupirocin, and has potential as a host for industrial production of a range of valuable products. To underpin further studies on its genetics and physiology, we have used a combination of standard and atypical approaches to achieve a quality of the genome sequence and annotation, above current standards for automated pathways. Assembly of Illumina reads to a PacBio genome sequence created a retrospectively hybrid assembly, identifying and fixing 415 sequencing errors which would otherwise affect almost 5% of annotated coding regions. Our annotation pipeline combined automation based on related well-annotated genomes and stringent, partially manual, tests for functional features. The strain was close to P. synxantha and P. libaniensis and was found to be highly similar to a strain being developed as a weed-pest control agent in Canada. Since mupirocin is a secondary metabolite whose production is switched on late in exponential phase, we carried out RNAseq analysis over an 18 h growth period and have developed a method to normalise RNAseq samples as a group, rather than pair-wise. To review such data we have developed an easily interpreted way to present the expression profiles across a region, or the whole genome at a glance. At the 2-hour granularity of our time-course, the mupirocin cluster increases in expression as an essentially uniform bloc, although the mupirocin resistance gene stands out as being expressed at all the time points.
Conflict of interest statement
I have read the journal’s policy and the authors of this manuscript have the following competing interests: Authors specified as employees of GSK have competing interests because this work was part of a project to develop technology which would have value to GSK; all authors associated with the university of Birmingham have competing interests because the university of Birmingham would benefit financially if the joint project with GSK led to a process that was deemed to be profitable to GSK. This does not alter our adherence to PLOS ONE policies on sharing data and materials.
Figures
References
-
- Katz L, Baltz RH. Natural product discovery: past, present, and future. J Ind Microbiol & Biotech 2016; 43:155–176. - PubMed
-
- Chain EB, Mellows G. Structure of pseudomonic acid, an antibiotic from Pseudomonas fluorescens. J Chem Soc-Chem Comm 1974; 20:847–848.
-
- Curzons AD. Isolation of Pseudomonic Acid. US Patent 1978; 4639534.
-
- Whatling CA, Hodgson JE, Burnham MKR, Clarke NJ, Franklin FCH, Thomas CM. Identification of a 60 kb region of the chromosome of Pseudomonas fluorescens NCIB 10586 required for their biosynthesis of pseudomonic acid (mupirocin). Microbiology 1995; 141:973–982.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
